229 related articles for article (PubMed ID: 29550482)
1. Traditional Chinese medication Tongxinluo attenuates apoptosis in ox-LDL-stimulated macrophages by enhancing Beclin-1-induced autophagy.
Chen Y; Li M; Zhang Y; Di M; Chen W; Liu X; Yu F; Wang H; Zhen X; Zhang M
Biochem Biophys Res Commun; 2018 Jun; 501(2):336-342. PubMed ID: 29550482
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese Medication Tongxinluo Attenuates Lipidosis in Ox-LDL-Stimulated Macrophages by Enhancing Beclin-1-Induced Autophagy.
Chen Y; Yu F; Zhang Y; Li M; Di M; Chen W; Liu X; Zhang Y; Zhang M
Front Pharmacol; 2021; 12():673366. PubMed ID: 34248627
[TBL] [Abstract][Full Text] [Related]
3. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip.
Ma J; Qiao L; Meng L; Ma L; Zhao Y; Liu X; Ni M; Zhang Y
Biomed Pharmacother; 2019 May; 113():108767. PubMed ID: 30870720
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
[TBL] [Abstract][Full Text] [Related]
5. Luteolin Attenuates Foam Cell Formation and Apoptosis in Ox-LDL-Stimulated Macrophages by Enhancing Autophagy.
Zhang BC; Zhang CW; Wang C; Pan DF; Xu TD; Li DY
Cell Physiol Biochem; 2016; 39(5):2065-2076. PubMed ID: 27825167
[TBL] [Abstract][Full Text] [Related]
6. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction.
Wang Y; Kuang X; Yin Y; Han N; Chang L; Wang H; Hou Y; Li H; Li Z; Liu Y; Hao Y; Wei Y; Wang X; Jia Z
Biomed Pharmacother; 2022 Jan; 145():112367. PubMed ID: 34740097
[TBL] [Abstract][Full Text] [Related]
7. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts.
Li Q; Li N; Cui HH; Tian XQ; Jin C; Chen GH; Yang YJ
Exp Physiol; 2017 Apr; 102(4):422-435. PubMed ID: 28150462
[TBL] [Abstract][Full Text] [Related]
8. Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement.
Wang T; Zhang L; Hu J; Duan Y; Zhang M; Lin J; Man W; Pan X; Jiang Z; Zhang G; Gao B; Wang H; Sun D
J Mol Cell Cardiol; 2016 Sep; 98():108-16. PubMed ID: 27496379
[TBL] [Abstract][Full Text] [Related]
9. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
[TBL] [Abstract][Full Text] [Related]
10. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression.
Wang Z; Guo X; Zhang Q; Du G; Zeng Z; Zheng C; Wei Y
Int J Med Sci; 2021; 18(16):3652-3664. PubMed ID: 34790037
[No Abstract] [Full Text] [Related]
11. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
[TBL] [Abstract][Full Text] [Related]
12. Legumain suppresses OxLDL-induced macrophage apoptosis through enhancement of the autophagy pathway.
Sun W; Lin Y; Chen L; Ma R; Cao J; Yao J; Chen K; Wan J
Gene; 2018 Apr; 652():16-24. PubMed ID: 29414692
[TBL] [Abstract][Full Text] [Related]
13. Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury.
Cui H; Li X; Li N; Qi K; Li Q; Jin C; Zhang Q; Jiang L; Yang Y
J Cardiovasc Pharmacol; 2014 Aug; 64(2):180-90. PubMed ID: 24705173
[TBL] [Abstract][Full Text] [Related]
14.
Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
[No Abstract] [Full Text] [Related]
15. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
[TBL] [Abstract][Full Text] [Related]
16. Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice.
Song G; Zong C; Zhang Z; Yu Y; Yao S; Jiao P; Tian H; Zhai L; Zhao H; Tian S; Zhang X; Wu Y; Sun X; Qin S
Free Radic Biol Med; 2015 Oct; 87():58-68. PubMed ID: 26117323
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells.
Wu XL; Zheng B; Jin LS; Zhang RN; He M; Yang Z; Wen JK
Int J Clin Exp Pathol; 2015; 8(6):6323-33. PubMed ID: 26261508
[TBL] [Abstract][Full Text] [Related]
18. Cyclophilin A mediates the ox-LDL-induced activation and apoptosis of macrophages via autophagy.
Xue Z; Yuan W; Li J; Zhou H; Xu L; Weng J; Li X; Zhang X; Wang Z; Yan J
Int J Cardiol; 2017 Mar; 230():142-148. PubMed ID: 28038796
[TBL] [Abstract][Full Text] [Related]
19. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits.
Yu YH; Xu XQ; Wang Y; Sun SZ; Chen Y
Chin J Integr Med; 2006 Mar; 12(1):32-6. PubMed ID: 16571281
[TBL] [Abstract][Full Text] [Related]
20. Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE
Dai S; Wang B; Li W; Wang L; Song X; Guo C; Li Y; Liu F; Zhu F; Wang Q; Wang X; Shi Y; Wang J; Zhao W; Zhang L
Cell Death Dis; 2016 Dec; 7(12):e2498. PubMed ID: 27906187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
